Human organic cation transporter 3 mediates the transport of antiarrhythmic drugs

European Journal of Pharmacology
Habib HasannejadH Endou

Abstract

Antiarrhythmic drugs have been considered to be transported by the organic cation transport system. The purpose of this study was to elucidate the molecular mechanism underlying the transport of antiarrhythmic drugs using cells from the second segment of the proximal tubule (S2) cells of mice expressing human-organic cation transporter 3 (S2 human-OCT3). The antiarrhythmic drugs tested were cibenzoline, disopyramide, lidocaine, mexiletine, phenytoin, pilsicanide, procainamide and quinidine. Human-OCT3 mediated a time- and dose-dependent uptake of quinidine and lidocaine, with Km values of 216 and 139 microM, respectively. Human-OCT3 also mediated the uptake of disopyramide and procainamide but not that of phenytoin. All antiarrhythmic drugs tested inhibited histamine uptake mediated by human-OCT3 in a dose-dependent manner. The IC50 values of antiarrhythmic drugs for human-OCT3 ranged between 0.75 and 656 microM. Kinetic analysis revealed that disopyramide, lidocaine, procainamide and quinidine inhibited histamine uptake mediated by human-OCT3 in a competitive manner. In conclusion, these results suggest that human-OCT3 mediates the transport of antiarrhythmic drugs, which may be the mechanism underlying the distribution and th...Continue Reading

References

Sep 4, 1976·Lancet·S Sherman, N Roizen
Oct 1, 1993·Physiological Reviews·J B Pritchard, D S Miller
Jul 1, 1997·DNA and Cell Biology·V GorboulevH Koepsell
Mar 20, 1999·Biochimica Et Biophysica Acta·M OkudaK Inui
Jul 1, 1999·Molecular Pharmacology·D GründemannE Schömig
Oct 19, 1999·Archives of Disease in Childhood. Fetal and Neonatal Edition·E Hey
Sep 1, 2000·American Journal of Physiology. Renal Physiology·X WuV Ganapathy
Aug 15, 2001·American Journal of Physiology. Renal Physiology·P ArndtH Koepsell
Mar 26, 2002·Journal of the American Society of Nephrology : JASN·Hideyuki MotohashiKen-Ichi Inui
Jul 20, 2002·The Journal of Pharmacology and Experimental Therapeutics·De-Sheng WangYuichi Sugiyama
Aug 15, 2002·Biochemical and Biophysical Research Communications·Mari KakehiYasufumi Sawada
Jan 16, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tyra M Leazer, Curtis D Klaassen
Apr 5, 2003·Journal of Neurochemistry·Tiesong ShangCecilia J Hillard

❮ Previous
Next ❯

Citations

Feb 2, 2013·Drug Metabolism Reviews·Eva RamboerMathieu Vinken
Mar 23, 2012·Expert Opinion on Drug Metabolism & Toxicology·Aditi MulgaonkarDouglas H Sweet
Jan 19, 2011·Expert Opinion on Drug Metabolism & Toxicology·Giuliano Ciarimboli
Oct 31, 2007·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S OswaldH K Kroemer
Aug 1, 2008·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·G Ciarimboli
Jul 3, 2015·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Liping LiHuidi Jiang
Jul 18, 2014·Critical Care : the Official Journal of the Critical Care Forum·Peter H J van der VoortPeter Pickkers
Jun 22, 2010·Journal of Pharmacological Sciences·Takeshi SakataHitoshi Endou
Mar 3, 2006·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Philipp SchlatterJuergen Drewe
Feb 18, 2017·Clinical Pharmacokinetics·Anton IvanyukThierry Buclin
Apr 30, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Liping LiHuidi Jiang
Nov 25, 2011·Expert Review of Clinical Pharmacology·Anne T Nies, Matthias Schwab
Dec 20, 2019·Pharmacological Reviews·Hermann Koepsell
Jun 16, 2012·International Journal of Immunopathology and Pharmacology·A ChiapporiG W Canonica

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.